SceneRay Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Series D1
- Latest Deal Amount
-
$46.9M
- Investors
-
9
SceneRay General Information
Description
Manufacturer of implantable neurostimulation devices intended to treat neurological and psychiatric disorders through deep brain stimulation technology. The company offers brain-computer interface devices, implantable neurostimulation systems, programmable therapy platforms, and patient management tools, enabling healthcare providers and patients with neurological and mental health conditions to receive targeted neural modulation and improve clinical outcomes.
Contact Information
Website
www.sceneray.comCorporate Office
- 3-4F, Jingyu Medical Building
- Number 71 Xinqing Road
- Suzhou, Jiangsu 215123
- China
Corporate Office
- 3-4F, Jingyu Medical Building
- Number 71 Xinqing Road
- Suzhou, Jiangsu 215123
- China
SceneRay Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series D1) | 01-Dec-2021 | $46.9M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series D) | 21-Apr-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C1) | 01-Sep-2017 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 03-Aug-2017 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 05-Aug-2015 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 13-Aug-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 18-Mar-2014 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jan-2012 | Completed | Startup |
SceneRay Patents
SceneRay Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026170754-A1 | Split stent, directional electrode, and implantable stimulation system | Pending | 14-Feb-2025 | ||
| WO-2026166116-A1 | Electrode stimulation electric field simulation method and apparatus, electronic device, and storage medium | Pending | 06-Feb-2025 | ||
| WO-2026148948-A1 | Electrode direction recognition method and apparatus, and device, medical system, medium and product | Pending | 13-Jan-2025 | ||
| WO-2026148951-A1 | Stimulation electric field display method, apparatus, system, device, medium, and product | Pending | 08-Jan-2025 | ||
| WO-2026144297-A1 | Electrode lead and neural stimulation system | Pending | 31-Dec-2024 |
SceneRay Signals
SceneRay Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GL Ventures | Venture Capital | Minority | ||
| HSG (Hong Kong) | Venture Capital | Minority | ||
| Juntong Capital | Venture Capital | Minority | ||
| DYEE Capital | Asset Manager | Minority | ||
| Yanchuang Capital | Growth/Expansion | Minority |
SceneRay FAQs
-
When was SceneRay founded?
SceneRay was founded in 2011.
-
Where is SceneRay headquartered?
SceneRay is headquartered in Suzhou, China.
-
What is the size of SceneRay?
SceneRay has 120 total employees.
-
What industry is SceneRay in?
SceneRay’s primary industry is Therapeutic Devices.
-
Is SceneRay a private or public company?
SceneRay is a Private company.
-
What is the current valuation of SceneRay?
The current valuation of SceneRay is .
-
What is SceneRay’s current revenue?
The current revenue for SceneRay is .
-
How much funding has SceneRay raised over time?
SceneRay has raised $72.2M.
-
Who are SceneRay’s investors?
GL Ventures, HSG (Hong Kong), Juntong Capital, DYEE Capital, and Yanchuang Capital are 5 of 9 investors who have invested in SceneRay.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process